Lactobacillus fermentum PCC 10568 04a J

Lactobacillus fermentum (PCC®)

Facts about Lactobacillus fermentum (PCC®)

  • Identified as Lactobacillus fermentum

  • Strain deposit number: NM02/31074

  • Originates from a healthy human 

  • PCC® is a registered trademark of Bioxyne Ltd.

  • Used since 2002, with no reported consumer illness or injury

  • Tested in clinical studies in doses up to 12 billion CFU/day, with no reported serious adverse events

A “young” and award-winning strain

Lactobacillus fermentum (PCC®) is one of the most recent additions to our selection of premium probiotic strains. In 2010 at Health Ingredients Europe, the PCC® strain won the prestigious Health Ingredients Excellence Award in the Sports Performance category. We have global exclusive rights to manufacture and sell Lactobacillus fermentum (PCC®).

In Europe, Lactobacillus fermentum has been granted Qualified Presumption of Safety (QPS) status since 2007 by the European Food Safety Authority (EFSA) – a status granted on species level.

Clinical studies 

Clinical studies indicate that the PCC® probiotic strain may have beneficial effects in the immune area:

  • May reduce respiratory tract challenges1
  • May enhance immune response
  • May alleviate symptoms of irritated skin3 

Nothing on this page is meant to be perceived as an approved claim.

Your opportunities 

We offer Lactobacillus (PCC®) for dietary supplements and fermented milk products. Please contact us for more information about the probiotic strain.

Cox et al. 2008, West et al. 2011
French et al. 2009
Weston et al. 2005

Share this with: